Home
/
Silo Pharma, Inc.
/
Financials
/
Quarterly
Silo Pharma, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Silo Pharma, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$18.0K
Nov 13, 2025
Q2
2025
Jun 30, 2025
$18.0K
Aug 13, 2025
Q1
2025
Mar 31, 2025
$18.0K
May 9, 2025
Q3
2025
Sep 30, 2024
$18.0K
Nov 13, 2025
Q2
2025
Jun 30, 2024
$18.0K
Aug 13, 2025
Q1
2025
Mar 31, 2024
$18.0K
May 9, 2025
Q3
2024
Sep 30, 2023
$18.0K
Nov 12, 2024
Q2
2024
Jun 30, 2023
$18.0K
Aug 13, 2024
Q1
2024
Mar 31, 2023
$18.0K
May 13, 2024
Q3
2023
Sep 30, 2022
$18.0K
Nov 13, 2023
Q2
2023
Jun 30, 2022
$18.0K
Aug 11, 2023
Q2
2021
Jun 30, 2021
$68.1K
Aug 13, 2021
Q1
2021
Mar 31, 2021
$47.4K
May 17, 2021
Q3
2020
Sep 30, 2020
$16.3K
Nov 5, 2020
Q2
2021
Jun 30, 2020
$2.2K
Aug 13, 2021
Q1
2021
Mar 31, 2020
$294
May 17, 2021
Q3
2020
Sep 30, 2019
$268
Nov 5, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.11M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($1.20M)
Aug 13, 2025
Q3
2025
Jun 30, 2025
($1.20M)
Nov 13, 2025
Q2
2025
Mar 31, 2025
($1.03M)
Aug 13, 2025
Q3
2025
Mar 31, 2025
($1.03M)
Nov 13, 2025
Q1
2025
Mar 31, 2025
($1.03M)
May 9, 2025
Q3
2025
Sep 30, 2024
($928.8K)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($931.8K)
Aug 13, 2025
Q3
2025
Jun 30, 2024
($931.8K)
Nov 13, 2025
Q1
2025
Mar 31, 2024
($801.7K)
May 9, 2025
Q2
2025
Mar 31, 2024
($801.7K)
Aug 13, 2025
Q3
2025
Mar 31, 2024
($801.7K)
Nov 13, 2025
Q3
2024
Sep 30, 2023
($660.2K)
Nov 12, 2024
Q3
2024
Jun 30, 2023
($1.01M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($1.01M)
Aug 13, 2024
Q2
2024
Mar 31, 2023
($906.4K)
Aug 13, 2024
Q3
2024
Mar 31, 2023
($906.4K)
Nov 12, 2024
Q1
2024
Mar 31, 2023
($906.4K)
May 13, 2024
Q3
2023
Sep 30, 2022
($983.2K)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($658.4K)
Aug 11, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.15M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($1.25M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($1.09M)
May 9, 2025
Q3
2025
Sep 30, 2024
($1.01M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($1.00M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($879.5K)
May 9, 2025
Q3
2024
Sep 30, 2023
($773.4K)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($1.11M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($803.5K)
May 13, 2024
Q3
2023
Sep 30, 2022
($949.2K)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($494.3K)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($527.3K)
May 12, 2023
Q3
2022
Sep 30, 2021
($463.9K)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($436.8K)
Aug 1, 2022
Q1
2022
Mar 31, 2021
($901.1K)
May 13, 2022
Q3
2021
Sep 30, 2020
($558.9K)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($996.7K)
Aug 13, 2021
Q1
2021
Mar 31, 2020
($159.4K)
May 17, 2021
Q3
2020
Sep 30, 2019
($242.5K)
Nov 5, 2020
Q2
2020
Jun 30, 2019
($189.9K)
Aug 14, 2020